Delivery Order SPE2DR25D1202-SPE2DR26F72WE
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 22, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a biologic medication used to treat inflammatory conditions. This is a firm fixed-price delivery order with a ceiling value of $4,531.80 and an ultimate completion date of May 23, 2025. The contract is non-competitive with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $5,330.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a injectable medication used to treat autoimmune conditions. The contract, with an ultimate completion date of September 10, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was made on a competitive basis with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a biologic medication used to treat autoimmune conditions. The contract is a firm fixed-price delivery order with a ceiling value of $1,193.97 and an ultimate completion date of November 25, 2025. This award is non-set-aside and represents a competitive procurement action. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $1,959.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL on December 8, 2025, with completion targeted for December 9, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a biologic medication used to treat inflammatory conditions. This firm fixed-price delivery order, valued at $1,575.72, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The award was made on a...
- The Defense Logistics Agency awarded a $4,358.22 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on December 4, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vehicle designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL with a firm fixed price ceiling value of $9,063.60 and an ultimate completion date of May 5, 2025. This non-set-aside, competitively awarded contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $12,288.46 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical supplies. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and specifies Conshohocken, Pennsylvania as the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls with a ceiling value of $15,815.48 under a firm fixed-price contract. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made on a competitive basis with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,768.16 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used for treating autoimmune conditions. The contract was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72WEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a biologic medication used to treat autoimmune conditions. This firm fixed-price delivery order, valued at $2,473.70, is a non-set-aside award with an ultimate completion date of December 10, 2025. The contract represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. AmerisourceBergen's Corporate Office division, located in Conshohocken, Pennsylvania, is the awardee, which serves as the company's primary headquarters and a major hub for its federal contracting operations. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime indefinite delivery vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and the U.S. Coast Guard. As a child contract under this major IDC, the HUMIRA delivery order exemplifies the company's role as a critical pharmaceutical distributor for federal medical procurement, fulfilling specific drug requirements through a streamlined ordering mechanism that supports the Defense Department's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/8/25 |